← All Fresenius Medical Care AG filings

Fresenius Medical Care AG 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NYSE
FMS
Fresenius Medical Care AG
20-F: Fresenius Medical Care Reports Strong 2025 Earnings, Accelerates Share Buyback
Fresenius Medical Care AG announced a significant increase in net income and operating income for 2025, alongside an accelerated share buyback program and strategic portfolio optimization.
NYSE
FMS
Fresenius Medical Care AG
20-F: Fresenius Medical Care AG Releases 20-F Filing for Fiscal Year 2024
Fresenius Medical Care AG's 20-F filing summarizes the company's financial performance, key events, and risk factors for the fiscal year ended December 31, 2024.
NYSE
FMS
Fresenius Medical Care AG
20-F: Fresenius Medical Care Enhances Brand Protection and Governance with Trademark License Agreement Amendment
Fresenius Medical Care amends its trademark license agreement to strengthen brand governance and address potential conflicts with parent company Fresenius SE.